A Phase 4 interventional study of Light therapy in Sleep, Mild Cognitive Impairment and Mood Disorders, sponsored by Stanford University. Not yet recruiting at 1 site in United States. Open to participants aged 65 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-25.
Sponsored by Stanford University · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Cognitive Dysfunction by Stanford University — 3 open to participants now, 7 under way, none of them phase 3. Cognitive Dysfunction · Stanford University.
Among the 14 studies in Cognitive Dysfunction by Stanford University, this one is the only one that started in 2026, is the only one in phase 4, and was the 9th registered.
3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.
Browse Cognitive Dysfunction studies →3 of the 14 studies in Cognitive Dysfunction by Stanford University are open now, in 1 country. Recruiting first, the newest first:
Stanford University · Sites in United States
Ages 6–12 · Healthy volunteers
Stanford University · Sites in United States
Ages 55+
By country, each count listing its studies:
Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 65 Years to 99 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 1 started in 2026.
This study's planned enrollment of 120 is above the median of 64 across 2,804 interventional studies indexed under Cognitive Dysfunction.
Median enrollment 135 across the 6 interventional studies, 85 across the 8 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.
Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.
2 of the studies in Cognitive Dysfunction by Stanford University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05201534Stanford UniversityInterventions in Mathematics and Cognitive Skills | 2027-08-31 |
| NCT06489847Stanford UniversityAn Objective Assessment Tool for Evaluating Functioning in Older Adults | 2027-10-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 14 studies in Cognitive Dysfunction by Stanford University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This trial will examine scheduled exposure to bright light in the morning and afternoon as a countermeasure to sleep fragmentation in older individuals with mild cognitive impairment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
One hour of daily bright light exposure beginning one hour after wake time.
Behavioral: Light therapy
One hour of daily bright light exposure in the afternoon
Behavioral: Light therapy
One hour of exposure to bright light, either by being outdoors or with a phototherapy lamp if indoor
Sleep fragmentation
24 hour sleep wake patterns will be quantitated with a non-parametric measure, intradaily variation
Time frame: 4 weeks
Cognition
Performance on the WAIS-4
Time frame: 6 months
Mood
Geriatric Depression Scale, range: 0-15 with higher scores being associated with greater depressive symptomatology
Time frame: 6 months
Plan to share: Yes — After completion of study and publication of data, deidentified IPD will be uploaded to Dryad with documentation. Analytic code will be shared with Github
Supporting information: Study protocol, Statistical analysis plan, Analytic code
Time frame: within six months after publication; no restrictions on duration of availability
Data sharing details ↗ · laneguides.stanford.edu
No publications or documents are linked to this record.
Start is estimated for Jun 2026; primary completion for May 2028, 23 months later.
Of 43 non-industry phase 4 interventional studies under Cognitive Dysfunction, half reached primary completion within 55 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 69. This study's planned 23 months is below that.
Counting every sponsor, half of 51 studies reached it within 54 months; a quarter within 20 and three quarters within 69.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.